Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christopher Leitheiser"'
Autor:
Sheila Ranganath, Ashok Bhandari, Nicole Avitahl-Curtis, Jaimee McMahon, Derek Wachtel, Jenny Zhang, Christopher Leitheiser, Sylvie G Bernier, Guang Liu, Tran T Tran, Herodion Celino, Jenny Tobin, Joon Jung, Hong Zhao, Katie E Glen, Chris Graul, Aliesha Griffin, Wayne C Schairer, Carolyn Higgins, Tammi L Reza, Eva Mowe, Sam Rivers, Sonya Scott, Alex Monreal, Courtney Shea, Greg Bourne, Casey Coons, Adaline Smith, Kim Tang, Ramya A Mandyam, Jaime Masferrer, David Liu, Dinesh V Patel, Angelika Fretzen, Craig A Murphy, G Todd Milne, Mark L Smythe, Kenneth E Carlson
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0141330 (2015)
Interleukin-6 (IL-6) is an important member of the cytokine superfamily, exerting pleiotropic actions on many physiological processes. Over-production of IL-6 is a hallmark of immune-mediated inflammatory diseases such as Castleman's Disease (CD) and
Externí odkaz:
https://doaj.org/article/79b1eaa807e1438c8eaa8708c553dbc5
Autor:
Alexandra Rezvaya, Fay Dufort, Christopher Leitheiser, Hannah Gardner, Tucker Ezell, Liuhong Chen, Peter Brown, Philip Brandish, Michael Skynner, Kevin McDonnell, Nicholas Keen
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Lukas Stanczuk, Johanna Lahdenranta, Fay Dufort, Christopher Leitheiser, Punit Upadhyaya, Kevin McDonnell, Philip Brandish, Nicholas Keen
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Liuhong Chen, Eric Haines, Philip E. Brandish, Katie Gaynor, Liudvikas Urbonas, Fay J. Dufort, Gemma Mudd, Elizabeth Repash, Nicholas Keen, Sandra Uhlenbroich, Christopher Leitheiser, Heather K. Allen, Julia Kristensson, Helen Harrison, Alexandra Rezvaya, Kevin McDonnell
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A824-A824
BackgroundNatural killer (NK) cells are immune cells that can detect and eliminate tumor cells and bridge innate to adaptive immune responses. Tumor specific activation of NK cells is thus an area of active investigation in immune oncology, but to da